Showing 1911-1920 of 4166 results for "".
- Some Biologics May Be Better Than Others for Averting Anterior Uveitishttps://modernod.com/news/some-biologics-may-be-better-than-others-for-averting-anterior-uveitis/2477890/Among patients with ankylosing spondylitis or undifferentiated spondyloarthritis, risk for anterior uveitis may hinge on the choice of biologic disease-modifying antirheumatic drug (bDMARD), a large Swedish cohort study suggests, according to a Medscape
- Clerio Vision: First Noninvasive Laser Vision Correction Procedures Performedhttps://modernod.com/news/clerio-vision-first-noninvasive-laser-vision-correction-procedures-performed/2479743/Leveraging technology developed at the University of Rochester that was recently recognized with a Nobel Prize, Clerio Vision is commercializing LIRIC—a novel, noninvasive method to correct human vision. The core technology has been in development for more than 15 year
- SightGlass Vision Presents Clinical Trial Data From Novel Lenses to Control Myopiahttps://modernod.com/news/sightglass-vision-presents-clinical-trial-data-from-novel-lenses-to-control-myopia/2476541/SightGlass Vision announced that data assessing the tolerability of three iterations of its novel lenses designed to control nearsightedness in children were presented at the Association for Research in Vision and
- Ace Vision Group Appoints Cristos Ifantides, MD, as Director, Clinical Applications Developmenthttps://modernod.com/news/ace-vision-group-appoints-cristos-ifantides-md-as-director-clinical-applications-development/2481436/Ace Vision Group (AVG) announced the appointment of Cristos Ifantides, MD, MBA, as Director, Clinical Applications Development, effective immediately. In his new role, Dr. Ifantides will lead the education and clinical adoption efforts of AVG's forthcoming presbyopia technology
- Kubota Vision Receives Orphan Products Clinical Trial Grant for Stargardt Disease Treatment Candidatehttps://modernod.com/news/kubota-vision-receives-orphan-products-clinical-trials-grants-to-emixustat-for-stargardt-disease/2478187/Kubota Vision announced that the FDA Office of Orphan Products Development (OOPD) has awarded an orphan products clinical trial grant to support the ongoing phase 3 study of emixustat in Stargardt disease. Orphan product clinical trial grants support well-controlled studies that will eithe
- Oculis Announces Publication of Positive Phase 2 Data Investigating Topical Anti-TNFα Agent Licaminlimab (OCS-02) in Acute Anterior Uveitishttps://modernod.com/news/oculis-announces-publication-of-positive-phase-2-data-investigating-topical-anti-tnfa-agent-licaminlimab-ocs-02-in-acute-anterior-uveitis/2481255/Oculis announced that the results of an active-controlled, multicenter, randomized, parallel-group phase 2 clinical trial assessing the effect of topical licaminlimab (OCS-02) on anterior chamber (AC) cell grade in patients with acute anterior uveitis (AAU) (NCT02482129) has been publis
- Show Organizers Announce that Vision Expo+, a Complimentary, Virtual Extension of the Vision Expo Experience Will be Offered April 1–8, 2022https://modernod.com/news/show-organizers-announce-that-vision-expo-a-complimentary-virtual-extension-of-the-vision-expo-experience-will-be-offered-april-1-8-2022/2480715/The Vision Council and RX, co-organizers of Vision Expo, announced that Vision Expo+, a complimentary digital extension of the Vision Expo experience, will be offered from Friday April 1 to Friday, April 8, 2022. Vision Expo+ will be delivered through
- Johnson & Johnson Vision Launches Veritas Vision Systemhttps://modernod.com/news/johnson-johnson-vision-introduces-veritas-vision-system-with-features-to-address-key-unmet-needs-in-cataract-surgery/2479401/Johnson & Johnson Vision announced the global availability of the Veritas Vision System, a next-generation phacoemulsification system designed to address three critical areas: patient safety, surgeon efficiency and comfort. The company will offer live demos of the new system in a wet lab at t
- Web Vision Technologies Receives Grants to Develop Vision Testing Devices for NASAhttps://modernod.com/news/web-vision-technologies-receives-grants-to-develop-vision-testing-devices-for-nasa/2479953/Web Vision Technologies was recently awarded two grants from Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine to develop vision-testing devices for the National Aeronautical Space Administration (NASA) to be used on the International Space Station (ISS). The
- Vision Expo West 2022 Opens Hotel Reservationshttps://modernod.com/news/vision-expo-west-2022-opens-hotel-reservations/2480917/The Vision Council and RX, co-organizers of Vision Expo, announced that reservations are now being accepted at Vision Expo West’s partner hotels for